WPC Banner  
 
 

Conferences Dedicated to Preclinical Models in Oncology at World Preclinical Congress 2015

Despite the tremendous progress in our understanding of cancer biology, most novel anticancer therapies fail in Phase 3 clinical trials. This situation brings into question the quality of preclinical tumor models and predictability of preclinical studies in oncology. Cambridge Healthtech Institute is proud to announce a comprehensive cluster of conferences dedicated to preclinical models in oncology. In two back to back conferences, there will be discussions of general strategies in preclinical modeling in oncology, approaches to use patient-derived xenograft models to inform clinical trials and patient care, and models for preclinical assessment of cancer immunotherapy. Imaging in preclinical and clinical trials in oncology will be featured in the third meeting of the cluster. Join pharmaceutical, biotech, and academic stakeholders June 10-12 in Boston for interactive sessions, panel discussions, and short courses, all geared toward providing opportunities for active networking and collaborating, while also giving the chance to gain strategic insight into solutions for increasing the predictability of preclinical cancer studies.

Submit Speaker Proposal 


Arrow 2014 Final Brochure 


Arrow View All Sponsors

Arrow View All Media Partners 


SPONSORSHIPS & EXHIBITS

The exhibit hall has sold out the past four years, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2015, contact:

Joseph Vacca
Associate Director, Business Development
781-972-5431
jvacca@healthtech.com 

 

 

Testimonials

WPC Quotes